Hookipa Pharma Inc (HOOK) Insider Bros. Advisors Lp Baker Purchases 892,857 Shares

Hookipa Pharma Inc (NASDAQ:HOOK) insider Bros. Advisors Lp Baker bought 892,857 shares of the firm’s stock in a transaction that occurred on Tuesday, April 23rd. The stock was acquired at an average cost of $14.00 per share, with a total value of $12,499,998.00. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink.

Hookipa Pharma stock traded down $0.25 during mid-day trading on Tuesday, reaching $13.75. The company’s stock had a trading volume of 85,867 shares, compared to its average volume of 596,810. Hookipa Pharma Inc has a 12 month low of $13.71 and a 12 month high of $14.76.

TRADEMARK VIOLATION WARNING: This piece was first reported by WKRB News and is owned by of WKRB News. If you are reading this piece on another site, it was illegally copied and reposted in violation of international copyright & trademark legislation. The correct version of this piece can be viewed at https://www.wkrb13.com/2019/04/24/hookipa-pharma-inc-hook-insider-bros-advisors-lp-baker-purchases-892857-shares.html.

Hookipa Pharma Company Profile

HOOKIPA Pharma Inc, a clinical-stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase 2 clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors.

Recommended Story: Quick Ratio

Receive News & Ratings for Hookipa Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hookipa Pharma and related companies with MarketBeat.com's FREE daily email newsletter.